-
Characterizing Genomic Variants Defining a Plasma Cell Disorder Patient Cohort Using a Broad Next Generation Multi-Gene DNA Sequencing Panel
Kristin Ezell, Katharine Hooper, Kaylyn Kirk, Ritika Vankina, Swarup Kumar Blood (2024) 144 (Supplement 1): 3314. 2024 Nov;
-
Racial and Socioeconomic Disparities in Patients with Waldenström’s Macroglobulinemia. a SEER Database Analysis
Alvaro Alvarez Soto, Junmin Song, Jackson Clark, Katharine Hooper, Maxine Amber Braun, Princy Shah and Swarup Kumar Blood (2024) 144 (Supplement 1): 2406. 2024 Nov;
-
Treatment of Aggressive B Cell Lymphoma with Epcoritamab - Real World Single Institution Experience
Manaswini Krishnakumar, Swarup Kumar, Maha Zafar, Aswanth Reddy Blood (2024) 144 (Supplement 1): 6536 2024 Nov;
-
A case of gamma heavy chain disease: a rare B-cell disorder with successful therapeutic response
Jackson Clark, Ritika Vankina, Swarup Kumar 2022 Oct;
-
Blue toes and monoclonal protein: a rare presentation of monoclonal gammopathy of renal significance and a novel treatment approach
Jackson Clark, Swarup Kumar 2022 Oct;
-
Deep learning identifies morphological changes in whole slide images of treatment-resistant TNBC
Ali Foroughi Pour; Te-Chia Wu; Jan Martinek; Swarup Kumar; Tobias Anzeneder; Stephanie Torkler; Franziska Sommermeyer; Karolina Palucka; Jeffrey Chuang Cancer Research 2022 Feb;(82):P1-02-01
-
Mast Cell Leukemia after t(8,21)AML ; a challenge in diagnosis and treatment
Lakshmi Kolandra, William Baker, Swarup Kumar, Meghana Singh, Adriana Kahn NNECOS annual meeting 2021 2021 Oct;
-
An evaluation of patient workflow in hematology clinics at a university hospital referred for the workup of monoclonal gammopathy of undetermined significance (MGUS)
Swarup Kumar, Radhika B Kulkarni, Gonca Ozcan, Asha Tipirneni, Ritika Vankina, and W. Jeffrey Baker Journal of Clinical Oncology 2021 Oct;39(28):207-207
-
Amy Huang, Nicole Sequeira, Anthony Zhang, Ursula Matos, Elan Gorshein, Talib Dosani, Ritika Vankina, Syed Ali, Natalia Neparidze, Swarup Kumar. Optimizing skeletal health: An analysis of bone-modifying agent prescription patterns and incidence of skeletal-related events in multiple myeloma. Blood 146(Supplement 1):4567-4567
-
Amy Huang, Ursula Matos, Anthony Zhang, Nicole Sequeira, Douglas Hackenyos, Ritika Vankina, Natalia Neparidze,Swarup Kumar. Optimizing Skeletal Health: A Retrospective Analysis of Bone-Modifying Agent Prescription Patterns and Incidence of Skeletal-Related Events in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia 25:S117
-
Andrea Moran, Swarup Kumar, Mrs. Elizabeth Marie Higgins, Meg Savage, Ruth LaCasse Kalish, Kapil Meleveedu. Development of an Electronic Medical Record-Based Template for Documentation of Mobilization/Collection and Pre-Transplant Evaluation. Transplantation and Cellular Therapy, Volume 32, Issue 2, Supplement, 2026
-
Arunachalam J, Bharathi V., Kumar S., Meleveedu K. Incidence and survival trends in mantle cell lymphoma involving tonsils: A SEER study. Society of Hematologic Oncology (SOHO) Annual Meeting 2025. September 2025
-
Ashish Sharma, Angad Tiwari, Harendra Kumar, Sukhmani Sidhu, Pavan Challa, Swarup Kumar. Disparities in venous thromboembolism management in patients with sickle cell disease: A nationwide inpatient sample study. Blood (2025) 146 (Supplement 1): 2974.
-
Ashish Sharma, Angad Tiwari, Harendra Kumar, Swarup Kumar. Duffy null phenotyping reduces unnecessary workup in asymptomatic neutropenia: A quality initiative in a correctional hematology clinic. Blood (2025) 146 (Supplement 1): 6545.
-
Ashish Sharma, Harendra Kumar, Angad Tiwari, Sukhmani Sidhu, Pavan Challa, Swarup Kumar. Impact of prolonged hospitalization on outcomes in acute leukemia: A national inpatient sample analysis
-
Chidambaram Ramasamy, Andrea Moran, Dong Chen, Swarup Kumar, Ritika Vankina, Kapil Meleveedu. Improving bone marrow biopsy core length and aspirate adequacy through implementation of a powered device: A single-institution quality improvement initiative. Blood 146(Supplement 1):6176-6176
-
Elizabeth Marie Higgins, Andrea Moran, Meg Savage, Terri Gillenwater, Vanessa Scanlon, Swarup Kumar, Kapil Meleveedu. Establishing Quality Infrastructure to Support Equitable Access to Autologous Stem Cell Transplantation at a Public Academic Medical Center. Transplantation and Cellular Therapy, Volume 32, Issue 2, Supplement,2026
-
Ezell, K., Steczko, O., Godin, S.L., Osadchyi, V., Meleveedu, K. and Kumar, S., 2025. Subclonal and Clonal Progression of Previously Characterized Mutations and Variants of Unknown Significance (VUS) Across a Cohort of Plasma Cell Dyscrasia Patients. Clinical Lymphoma, Myeloma and Leukemia, 25, p.S145
-
Godin, S.L., Ferraira, J., Hanna, C., Kumar, S., Meleveedu, K. Navigating Angioimmunoblastic T-Cell Lymphoma: A Diagnsotic Journey. Society of Hematologic Oncology (SOHO); September 3-6, 2025
-
Hamouche, R., Osadchyi, V., Hanna, C., Tashjian, H., Ezell, K., Godin, S.L., Meleveedu, K. and Kumar, S., 2025. Immune Correlates of Response to T-Cell Engaging Bispecific Antibody Treatments in Multiple Myeloma. Clinical Lymphoma, Myeloma and Leukemia, 25, p.S63
-
Kristin Ezell, Shea-Lee Godin, Nour Abdallah, Olivia Steczko, Chidambaram Ramasamy, Ritika Vankina, Kapil Meleveedu, Swarup Kumar. Examining TP53-mutated plasma cell disorders across the disease spectrum using broad next generation sequencing. Blood 146(Supplement 1):4013-4013
-
Kristin Ezell, Shea-Lee Godin, Vladimir Osadchyi,Olivia Steczko, Ritika Vankina, Kapil Meleveedu, Swarup Kumar. The Role of CHIP Mutations in Plasma Cell Dyscrasias: Implications for Clonal Evolution and Risk Stratification. Clinical Lymphoma, Myeloma and Leukemia 25:S145-S146
-
Meg Savage, Mrs. Elizabeth Marie Higgins, Swarup Kumar, Andrea Moran, Kapil Meleveedu. Coordinating Care Under Custody: Unique Workflow for Department of Correction Transplant Recipients, Transplantation and Cellular Therapy, Volume 32, Issue 2, Supplement, 2026
-
Olivia Steczko, Janani Arunachalam, Susmitha Talasila, Ritika Vankina, Swarup Kumar. Infusional Chemotherapy Regimens for Multiple Myeloma: Characterization of Current-Day Use at a Single Center. Clinical Lymphoma, Myeloma and Leukemia 25:S300
-
Salem, M., Kumar, S., Meleveedu, K. A Rare Manifestation of Pleural Effusion Post-Transplant Lymphoproliferative Disorder After Autologous Stem-Cell Transplant. Society of Hematologic Oncology (SOHO) Annual Meeting 2025. September 2025
-
Swarup Kumar, Kristin Ezell, Ritika Vankina. Diagnostic Patterns and Outcomes of Amyloidosis Screening in a Monoclonal Gammopathy Clinic: A Single Center Study. Clinical Lymphoma, Myeloma and Leukemia 25:S244-S245
-
Ursula Matos, Moana Divina Da Silva Santiago, Swarup Kumar, Gustavo Silva Sanchez ,Eduardo Dan, Patrick Froelich Meldola, Ritika Vankina. Efficacy and safety of low-dose vs. standard-dose direct oral anticoagulants for secondary prevention of cancer associated thrombosis: A systematic review and meta-analysis. Blood (2025) 146 (Supplement 1): 6682
-
Kirk K, Hooper K, Vankina R, Kumar S. Assessing the Development of Myelodysplastic Syndromes in Patients with Plasma Cell Dyscrasias. Blood (2023) 142 (Supplement 1): 6499.
-
Kolandra L, Bahgat J, Bernstein E, Petricca L, Ibrahim O, Kumar S. Lung cancer screening in the prison population. JCO Oncol Pract 19, 2023 (suppl 11; abstr 114).
-
Kumar S, Clark J, Alvarez‑Soto A, El Warrak S, Kumar S, Braish J, Reddy A. A single‑center treatment sequencing analysis in patients with relapsed/refractory multiple myeloma (RRMM). Clinical Lymphoma, Myeloma & Leukemia, Vol. 23, No. S2, S1-S356, 2023. P-280
-
Kumar S, Hooper K, Clark J, Alvarez‑Soto A, Rounds A. Early outcomes and therapy modification strategies in multiple myeloma patients treated with teclistamab, CD3XBCMA BITE: a single center experience. Clinical Lymphoma, Myeloma & Leukemia, Vol. 23, No. S2, S1-S356, 2023. P-024
-
Kumar S, Kirk K, Hooper , Vankina R. A retrospective assessment of biologically relevant genomic perturbations and variants of unknown significance in a cohort of plasma cell disorder at our institution; a single center experience. Clinical Lymphoma, Myeloma & Leukemia, Vol. 23, No. S2, S1-S356, 2023. P-384.
-
MM-361 Central Nervous System Relapse of Multiple Myeloma: A Case Report
Maha Zafar, Aswanth Reddy, Swarup Kumar Clinical Lymphoma Myeloma and Leukemia. Volume 24, Supplement 1, (September 2024), Pages S552-S553
-
Unusual Extramedullary Relapse in the Colon and Subcutaneous Tissue of a Patient With Multiple Myeloma
Maha Zafar, Aswanth Reddy, Swarup Kumar Clinical Lymphoma, Myeloma and Leukemia, Volume 24, S567
(September 2024)
-
Vankina R, Kirk K, Hooper K, Reddy A, Kumar S. Thrombotic significance in plasma cell disorders: do associated clonal hematopoiesis of indeterminate potential (CHIP) mutations increase the risk? Clinical Lymphoma, Myeloma & Leukemia, Vol. 23, No. S2, S1-S356, 2023. P-102
